At this year’s The American Society of Regional Anesthesia and Pain Medicine (ASRA) Annual Meeting, HSS physicians and scientists presented exciting new research related to advancements in regional anesthesia and pain management.

HSS Study Evaluates Non-Opioid Pain Relief Following Orthopedic Surgery

A retrospective study by investigators at HSS, found that a newly available non-opioid pain reliever was generally well tolerated by postoperative orthopedic surgery patients—an important step forward in advancing non‑opioid pain management options.

HSS Presents New Research Leveraging AI to Uncover Insights Related to Pain Risk and Anesthesia Education at ASRA Annual Meeting

Investigators at HSS presented significant studies leveraging artificial intelligence (AI) to provide insights into long-term pain risk after surgery and what patients want to know about anesthesia. These insights may ultimately help guide anesthesiologists’ consultations with patients scheduled for surgery.

HSS Studies Contribute Early Evidence to Help Guide Emerging Perioperative Considerations for Patients Using GLP 1 Medications

Researchers at HSS presented two studies focused on glucagon-like peptide-1 (GLP-1) agonist usage in patients undergoing surgery. GLP-1 agonists are a class of medications commonly prescribed to treat type 2 diabetes and obesity, and their therapeutic potential is extending to a range of conditions including cardiovascular and neurodegenerative diseases. These studies highlight the need for clear, evidence-based guidance as the use of GLP-1s expands.